Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Journal:

Journal of Clinical Oncology

Published:

2026-01-09

DOI:

10.1200/jco-25-01453

Affiliations:

13

Authors:

16

Go to article

Institutions	Authors	Share
UC San Diego Health Sciences, United States of America (USA)	6.166667	0.39
Moores Cancer Center, United States of America (USA)	4.833333	0.30
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.06
Kyoto University Hospital, Japan	1.000000	0.06
Dartmouth Cancer Center, United States of America (USA)	1.000000	0.06
The University of Texas MD Anderson Cancer Center, United States of America (USA)	1.000000	0.06
Foundation Medicine, Inc., United States of America (USA)	0.500000	0.03
State University of New York Upstate Medical University (SUNY Upstate Medical University), United States of America (USA)	0.500000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?